Asia-Pacific Cardiac Rehabilitation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Application, and End User

Asia-Pacific Cardiac Rehabilitation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Application, and End User

  • June 2021 •
  • 154 pages •
  • Report ID: 6103127 •
  • Format: PDF
The Asia Pacific cardiac rehabilitation market is expected to reach US$ 566.21 million by 2028 from US$ 357.64 million in 2021; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as rise in technologically advanced cardiac rehabilitation products and supportive government initiatives for cardiac rehabilitation. However, the high cost of the cardiac rehabilitation equipment is expected to obstruct the growth of the market to a certain extent during the forecast period.
Cardiac rehabilitation devices are used by patients suffering from heart diseases.These rehabilitation devices aid the patients in reducing the danger of heart attacks and heart diseases.

CR is an evidence-based, multidisciplinary intervention conferred to enhance health consequences and quality of life when used as secondary prevention.Several government initiatives are considered to have a high impact on the market.

Increasing awareness regarding the CR, growing referral of eligible patients, and reducing system and limitations of the patient cooperation in promoting the enrolment, referral, and participation rates in CR programs.Several manufacturers are working on advanced cardiac rehabilitation products.

Effective partnerships across teams, government agencies, community resources, and independent-sector resources are central to providing the proper support in the right place for everyone. Such strategic initiatives are likely to offer growth opportunities to the market players to attain a significant position and grow in the market. Also, several manufacturers are working on advanced cardiac rehabilitation products. For instance, in April 2019, Royal Philips launched an ultrasonic system EPIQ CVx to offer excellent image clarity and sharpness, upgraded exam efficiencies, as well as more robust and reproducible quantification enabled by anatomical intelligence along with extraordinary processing power. Therefore, the adoption of technologically advanced cardiac rehabilitation products is likely to be a prevalent trend during the forecast period.
Countries in Asia-Pacific are expecting to witness massive challenges due to the growing COVID-19.Considering the economic operations and geographic conditions, the pandemic has affected medical tourism, manufacturers of medical equipment, and other problems posed by the shortage of healthcare infrastructure in Asia Pacific low-income countries.

Due to rapidly changing risk of COVID-19 affected countries and always controlling outbreak trends, any additional health measures are likely to interfere with international travel and trade significantly. This is likely to have negative impact on the Asia Pacific cardiac rehabilitation market.
Based on product, the Asia Pacific cardiac rehabilitation market is segmented into heart rate monitor, stabilization balls, treadmill, rower, elliptical trainer, blood pressure monitor, stationary bicycle, and others. The treadmill segment held the largest share of the market in 2020, whereas the blood pressure monitor segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on application, the Asia Pacific cardiac rehabilitation market is segmented into angioplasty, coronary artery disease, cardiomyopathy, cholesterol management, diabetes, and lung transplant. The angioplasty segment held the largest share of the market in 2020, and the coronary artery disease segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on end user, the Asia Pacific cardiac rehabilitation market has been segmented into hospitals & clinics, specialty hospitals, home healthcare, cardiac rehabilitation centers, and others. The cardiac rehabilitation centers segment held the largest share of the market in 2020, and home healthcare segment is estimated to register the highest CAGR in the market during the forecast period.
A few of the primary and secondary sources associated with this report on the Asia Pacific cardiac rehabilitation market are the World Heart Federation (WHF), Australian Cardiovascular Health and Rehabilitation Association (ACRA), and World Health Organization (WHO).
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.